Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee

ClinicalTrials.gov ID: NCT01444365

Public ClinicalTrials.gov record NCT01444365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of ABT-652 as an Add On Therapy in Subjects With Osteoarthritis of the Knee Experiencing Partial Benefit of a Nonsteroidal Anti-Inflammatory Drug

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and efficacy of ABT-652 in combination with a Non-steroidal Anti-inflammatory Drug (NSAID) compared to NSAID alone in adults with osteoarthritis (OA) of the knee.

Study identification

NCT ID
NCT01444365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
202 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2011 (Type not available)
Primary completion
Apr 2012 (Actual)
Completion
Apr 2012 (Actual)
Last update posted
May 15, 2013

2011 – 2012

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
Site Reference ID/Investigator# 61226 Phoenix Arizona 85023 —
Site Reference ID/Investigator# 61221 Phoenix Arizona 85032 —
Site Reference ID/Investigator# 61241 Tucson Arizona 85704 —
Site Reference ID/Investigator# 61257 Anaheim California 92801 —
Site Reference ID/Investigator# 61246 Fresno California 93726 —
Site Reference ID/Investigator# 61242 La Mesa California 91942 —
Site Reference ID/Investigator# 61204 Long Beach California 90806 —
Site Reference ID/Investigator# 61258 North Hollywood California 91606 —
Site Reference ID/Investigator# 61265 Milford Connecticut 06460 —
Site Reference ID/Investigator# 61234 DeLand Florida 32720 —
Site Reference ID/Investigator# 61213 Ocala Florida 34471 —
Site Reference ID/Investigator# 61211 Oldsmar Florida 34677 —
Site Reference ID/Investigator# 61217 Orlando Florida 32806 —
Site Reference ID/Investigator# 61231 Plantation Florida 33317 —
Site Reference ID/Investigator# 61245 Tampa Florida 33603 —
Site Reference ID/Investigator# 61263 Marietta Georgia 30060 —
Site Reference ID/Investigator# 61210 Brockton Massachusetts 02301 —
Site Reference ID/Investigator# 61260 Watertown Massachusetts 02472-3930 —
Site Reference ID/Investigator# 61244 Florissant Missouri 63031 —
Site Reference ID/Investigator# 61266 St Louis Missouri 63141 —
Site Reference ID/Investigator# 61206 Omaha Nebraska 68134 —
Site Reference ID/Investigator# 61223 Salisbury North Carolina 28144 —
Site Reference ID/Investigator# 61273 Cincinnati Ohio 45245 —
Site Reference ID/Investigator# 61228 Oklahoma City Oklahoma 73109 —
Site Reference ID/Investigator# 61264 Portland Oregon 97239 —
Site Reference ID/Investigator# 61238 Duncansville Pennsylvania 16635 —
Site Reference ID/Investigator# 61205 Beaumont Texas 77701 —
Site Reference ID/Investigator# 61218 Bryan Texas 77802 —
Site Reference ID/Investigator# 61235 San Antonio Texas 78209 —
Site Reference ID/Investigator# 61232 Draper Utah 84020 —
Site Reference ID/Investigator# 61269 Franklin Wisconsin 53132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01444365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01444365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →